PTC THERAPEUTICS INC (PTCT) Stock Income Statement
NASDAQ:PTCT - Nasdaq - US69366J2006 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.77B | 806.78M | 937.82M | 698.80M | 538.60M | |||
| Cost Of Goods | 55.52M | 57.40M | 65.49M | 44.70M | 32.30M | |||
| Gross Profit | 1.72B | 749.38M | 872.34M | 654.10M | 506.30M | |||
| Operating Expenses | 843.75M | 891.65M | 1.09B | 1.07B | 880.70M | |||
| Research and Development | 527.32M | 534.48M | 666.56M | 651.50M | 540.70M | |||
| Selling, General, and Administrative Expenses | 308.60M | 300.91M | 332.54M | 326.00M | 285.80M | |||
| Operating Income | 873.48M | -142.27M | -221.70M | -414.00M | -374.40M | |||
| Interest Income/Expense | -170.15M | -168.59M | -125.18M | -109.60M | -100.40M | |||
| Other Income/Expense | 8.55M | 8.14M | 6.13M | -30.50M | -43.50M | |||
| Non Recurring Items | -60.48M | -60.40M | -355.36M | -33.40M | 0.00 | |||
| Income Before Taxes | 651.40M | -363.12M | -696.11M | -587.50M | -518.30M | |||
| Income Tax | 56.56M | 176.00K | -69.51M | -28.50M | 5.60M | |||
| Net Income | 594.84M | -363.30M | -626.60M | -559.00M | -523.90M | |||
| EBITDA | 900.97M | -66.61M | 14.89M | -285.16M | -310.27M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 6.50 | -4.73 | -8.37 | -7.79 | -7.43 | |||
| Non GAAP EPS | 5.23 | -6.01 | -6.54 | -7.33 | -7.43 | |||
| Statistics | ||||||||
| Gross Profit Margin | 96.87% | 92.89% | 93.02% | 93.60% | 94.00% | |||
| Profit Margin | 33.55% | -45.03% | -66.81% | -79.99% | -97.27% | |||
| Operating Profit Margin | 49.27% | -17.63% | -23.64% | -59.24% | -69.51% | |||
All data in USD